- Report
- April 2022
- 40 Pages
Vietnam
From €1481EUR$1,500USD£1,233GBP
- Report
- March 2022
- 100 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- February 2022
- 40 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Report
- February 2022
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- December 2021
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- December 2021
- 40 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2021
- 40 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2021
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- August 2021
- 40 Pages
United States
From €1481EUR$1,500USD£1,233GBP
- Report
- June 2021
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- November 2020
- 100 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- February 2020
- 40 Pages
South Korea
From €1481EUR$1,500USD£1,233GBP
- Report
- February 2020
- 100 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- January 2020
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- January 2020
- 40 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Training
- March 2023
- 2 Days
Global
From €1820EUR$1,843USD£1,514GBP
- Training
- June 2023
- 2 Days
Global
From €1455EUR$1,474USD£1,211GBP
- Report
- October 2024
- 70 Pages
China
From €938EUR$950USD£781GBP
- Report
- October 2024
- 70 Pages
France
From €938EUR$950USD£781GBP
- Report
- October 2024
- 70 Pages
Germany
From €938EUR$950USD£781GBP
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more